Atara brings another experienced investigator onto its off-the-shelf CAR-T quest in latest collaboration
An ambitious Atara has signed up another cancer research center to beef up its pipeline of off-the-shelf CAR-T therapies.
In the new collaboration, the Amgen spinoff $ATRA will “contribute resources and relevant experience to the research activities” at Moffitt Cancer Center in Tampa, FL. They will work closely with Marco Davila, a veteran researcher in the field who trained with top CAR-T investigator Michel Sadelain at Memorial Sloan Kettering.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.